Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsDividends payablesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Selectis Health (GBCS) Common Equity (2017 - 2025)

Selectis Health's Common Equity history spans 13 years, with the latest figure at -$6.2 million for Q4 2025.

  • Quarterly results put Common Equity at -$6.2 million for Q4 2025, down 14.79% from a year ago — trailing twelve months through Dec 2025 was -$6.2 million (down 14.79% YoY), and the annual figure for FY2025 was -$6.2 million, down 14.79%.
  • Common Equity for Q4 2025 was -$6.2 million at Selectis Health, down from -$5.7 million in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $5.0 million in Q1 2023 to a low of -$6.4 million in Q2 2025.
  • The 5-year median for Common Equity is $814799.0 (2022), against an average of -$591118.8.
  • The sharpest move saw Common Equity soared 684.92% in 2021, then tumbled 814.25% in 2024.
  • Year by year, Common Equity stood at $3.1 million in 2021, then tumbled by 69.29% to $952835.0 in 2022, then plummeted by 411.05% to -$3.0 million in 2023, then crashed by 82.54% to -$5.4 million in 2024, then dropped by 14.79% to -$6.2 million in 2025.
  • According to Business Quant data, Common Equity over the past three periods came in at -$6.2 million, -$5.7 million, and -$6.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.